E. David Crawford, MD, is a board-certified urologist who has devoted his career in medicine to educating the public about men's health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States. Dr. Crawford is an internationally recognized expert in benign prostate hypertrophy, urologic cancers, and in particular, prostate cancer. As a professor in the Department of Urology, he instructs medical students, residents and fellows at UC San Diego School of Medicine. Dr. Crawford has conducted research in the treatment of advanced bladder cancer, metastatic adenocarcinoma of the prostate, hormone refractory prostate cancer, and other areas of urological infections and malignancies. He has authored or coauthored over 810 scientific articles, published seven textbooks, authored over 60 book chapters and provided more than 2,200 educational talks for patients and physicians. He has served as editor in chief of Grand Rounds in Urology since June of 2019. In an effort to raise public awareness about prostate health, Dr. Crawford founded the Prostate Conditions Education Council (PCEC) in 1989. The non-profit organization is comprised of a consortium of leading physicians, health educators, scientists and men's health advocates. PCEC's advocacy for free or low-cost prostate screening has affected the lives of millions of American men. He currently chairs the PCEC. Consistently recognized as one of the Best Doctors of America for the past two decades, he has also ranked as one of the top 20 urologists in the country by Men's Health Magazine. In May of 2019, he received the presidential citation from the American Urological Association in recognition of his "tireless role in genitourinary cancer research that has benefited countless urologic cancer patients." In 2021, he was the recipient of the Merle Stringer, MD, award for excellence in medicine by the Florida State Medical Association. He is an active member of many national and international organizations, including the American Society of Clinical Oncology, American Urological Association (AUA) and the American Association for the Advancement of Science. Within the AUA, he has been a member of the Committee to Study Urologic Research Funding and the prostate cancer clinical trials subcommittee. Dr. Crawford served on the board of governors, the scientific advisory board of the Southwest Oncology Group and served as chairman of the Genitourinary Cancer Committee for 27 years. Dr. Crawford completed a fellowship in genitourinary cancer at UC Los Angeles David Geffen School of Medicine and a residency in urology at Good Samaritan Hospital in Cincinnati. He earned his medical degree from University of Cincinnati. Dr. Crawford is board certified in urology.